WEBVTT - Premier's DeVore on Healthcare: Improve Clinical Data (Audio)

0:00:02.360 --> 0:00:05.760
<v Speaker 1>Global business news twenty four hours a day at Bloomberg

0:00:05.800 --> 0:00:08.880
<v Speaker 1>dot Com, the Radio plus mobile. Last head on your radio.

0:00:09.160 --> 0:00:13.400
<v Speaker 1>This is a Bloomberg Business Flash call Bloomberg World Headquarters.

0:00:13.440 --> 0:00:16.079
<v Speaker 1>I'm Charlie Holt Stocks Laurel. Let's head right over to

0:00:16.120 --> 0:00:19.120
<v Speaker 1>the first Word breaking news desk for today's afternoon call.

0:00:19.239 --> 0:00:22.799
<v Speaker 1>Here he is Bill Maloney. Good afternoon, Charlie. US stocks

0:00:22.840 --> 0:00:25.360
<v Speaker 1>are under pressure today, with the DAL currently down a

0:00:25.440 --> 0:00:28.280
<v Speaker 1>hundred and ten points, SUPs drop ten and as that

0:00:28.480 --> 0:00:31.760
<v Speaker 1>falls eleven, the small cap six hundreds down three points.

0:00:31.800 --> 0:00:34.960
<v Speaker 1>In the US ten yield at one point five seven percent.

0:00:35.440 --> 0:00:38.120
<v Speaker 1>Nine out of tennesseev sectors are lower, led by losses

0:00:38.120 --> 0:00:42.959
<v Speaker 1>and energy industrials and telecom Fractional games for consumer discretionary

0:00:43.400 --> 0:00:48.840
<v Speaker 1>down transports fall seventy seven, nazerbotechs outperformed Game fourteen, utilities

0:00:48.920 --> 0:00:51.760
<v Speaker 1>drop three, and the vix is higher by eleven percent.

0:00:52.240 --> 0:00:54.960
<v Speaker 1>Down Leaders of the downside included Chevron, x On Mobile,

0:00:55.040 --> 0:00:59.000
<v Speaker 1>and Apple, while Nike, Walmart, and DuPont led to the upside.

0:00:59.440 --> 0:01:01.840
<v Speaker 1>Ro protect Alogy stall as much as eight point one

0:01:01.880 --> 0:01:05.280
<v Speaker 1>percent after its earnings. Well shares of Buffalo Wild Wings

0:01:05.280 --> 0:01:08.720
<v Speaker 1>seerves as much as seven percentage today after an activist

0:01:08.720 --> 0:01:12.000
<v Speaker 1>investor acquired a five point one percent steak. Find me

0:01:12.040 --> 0:01:14.800
<v Speaker 1>someone names such report after the belts to night include Gilead,

0:01:14.880 --> 0:01:19.160
<v Speaker 1>Las Vegas, Sands, Express Scripts, and Texas Instruments. Live on

0:01:19.240 --> 0:01:21.600
<v Speaker 1>the first and breaking newsdask on Bill Maloney, cho all right,

0:01:21.600 --> 0:01:23.839
<v Speaker 1>thank you very much, Bill Maloney. To hear live breaking

0:01:23.840 --> 0:01:27.040
<v Speaker 1>news over your Bloomberg time squaw caaskuu a w K

0:01:27.360 --> 0:01:30.919
<v Speaker 1>on your terminal. I'm Charlie pellout. Dan's a Bloomberg business

0:01:30.959 --> 0:01:36.760
<v Speaker 1>flash now on Bluebird Radio. We take stock of healthcare.

0:01:38.080 --> 0:01:40.800
<v Speaker 1>We call it k B for sure. It's a major

0:01:40.920 --> 0:01:44.560
<v Speaker 1>source of healthcare expenditures. The issue of drug pricing has

0:01:44.640 --> 0:01:46.840
<v Speaker 1>been at the forefront, certainly in the political ground for

0:01:46.840 --> 0:01:49.080
<v Speaker 1>the last few months. I think we're living in a

0:01:49.200 --> 0:01:53.320
<v Speaker 1>very special time in the history of the pharmaceutical industry.

0:01:53.480 --> 0:01:57.120
<v Speaker 1>Before we start any pharmaceutical discovery, we want to understand

0:01:57.120 --> 0:02:00.280
<v Speaker 1>the patient biology for three percent of all pilot next

0:02:00.280 --> 0:02:02.680
<v Speaker 1>to start actually get a drug of food. It's a

0:02:02.800 --> 0:02:06.080
<v Speaker 1>very hard thing to do. Bloomberg takings to healthcare and

0:02:06.160 --> 0:02:10.680
<v Speaker 1>focus on Bloomberg radios, the price the cost of healthcare

0:02:10.880 --> 0:02:15.640
<v Speaker 1>in focus. Joining us now Susan Devour, President chief executive

0:02:15.760 --> 0:02:20.720
<v Speaker 1>of Premiere. Premiere, of course one of the leading provider

0:02:20.800 --> 0:02:25.239
<v Speaker 1>driven healthcare performance improvement companies. Susan joins us now. Susan,

0:02:25.280 --> 0:02:28.280
<v Speaker 1>thanks very much for being with us. Thank you tell

0:02:28.360 --> 0:02:31.160
<v Speaker 1>us a little bit about a Premiere and the quest too,

0:02:31.200 --> 0:02:35.080
<v Speaker 1>as you describe it in many of your your articles,

0:02:35.120 --> 0:02:39.440
<v Speaker 1>the prescription to fixed healthcare. How does Premiere fit in? So,

0:02:39.600 --> 0:02:43.839
<v Speaker 1>Premiere is an alliance of healthcare systems. We work with

0:02:44.040 --> 0:02:47.680
<v Speaker 1>secent of the hospitals and health healthcare systems around the

0:02:47.720 --> 0:02:52.920
<v Speaker 1>country trying to drive quality improvement, cost reduction, safety improvement,

0:02:52.919 --> 0:02:56.320
<v Speaker 1>and really help healthcare systems transform the way they're taking

0:02:56.320 --> 0:02:58.720
<v Speaker 1>care of the millions of patients in this country. And

0:02:58.720 --> 0:03:02.080
<v Speaker 1>of course a big part of that is UH drug prices.

0:03:02.160 --> 0:03:05.680
<v Speaker 1>Drug costs represent about four percent of the United States

0:03:05.680 --> 0:03:09.280
<v Speaker 1>three trillion dollar annual health expenditure. They're growing rapidly, total

0:03:09.360 --> 0:03:12.240
<v Speaker 1>drug spending up twelve point two percent last year. As

0:03:12.280 --> 0:03:15.680
<v Speaker 1>you point out in a recent analysis, you are have

0:03:15.919 --> 0:03:20.200
<v Speaker 1>a lot of insight and suggestions here. I'm particularly interested

0:03:20.600 --> 0:03:24.560
<v Speaker 1>in how generic drug price increases are contributing to the

0:03:24.600 --> 0:03:29.080
<v Speaker 1>growth in drug spending. So thank you for the question,

0:03:29.160 --> 0:03:32.800
<v Speaker 1>and at Premiere we're focused every day on on the

0:03:32.880 --> 0:03:35.520
<v Speaker 1>cost of not only drugs, but medical devices and the

0:03:35.600 --> 0:03:38.600
<v Speaker 1>overall cost of care. And when you look at drugs spending,

0:03:39.080 --> 0:03:41.880
<v Speaker 1>as you said, UM, it's at at one of the

0:03:41.960 --> 0:03:45.840
<v Speaker 1>highest levels it's been at in decades. And we really

0:03:45.880 --> 0:03:50.480
<v Speaker 1>think it Premiere the opportunity to bring competitive friction UH

0:03:50.520 --> 0:03:55.760
<v Speaker 1>to the drug marketplace. UM. Pushing along faster FDA approval,

0:03:56.360 --> 0:04:00.840
<v Speaker 1>getting faster adoption, of continuing adoption of in erics, and

0:04:01.040 --> 0:04:07.080
<v Speaker 1>also of biosimilar drugs, bringing transparency to the industry, all

0:04:07.120 --> 0:04:10.160
<v Speaker 1>of those things we think will be helpful in bringing

0:04:10.240 --> 0:04:13.120
<v Speaker 1>drug prices down over time. Do you think that the

0:04:13.120 --> 0:04:17.760
<v Speaker 1>federal government should be able to negotiate drug prices? You know,

0:04:17.839 --> 0:04:21.440
<v Speaker 1>at Premiere, we don't think price controls work. We think

0:04:21.440 --> 0:04:24.640
<v Speaker 1>it's very hard for government to make those clinical decisions

0:04:24.720 --> 0:04:28.279
<v Speaker 1>or intervene in those clinical decisions. We also don't think

0:04:28.320 --> 0:04:31.560
<v Speaker 1>that they can work rapidly enough to keep up with

0:04:31.600 --> 0:04:34.000
<v Speaker 1>what it takes to bring new drugs to market and

0:04:34.120 --> 0:04:37.479
<v Speaker 1>to evaluate the clinical effectiveness of them. So we don't

0:04:37.520 --> 0:04:40.280
<v Speaker 1>think price controls work, and a Premiere, we don't think

0:04:40.600 --> 0:04:44.600
<v Speaker 1>reimportation works. What we think works is bringing competitive friction

0:04:45.080 --> 0:04:50.360
<v Speaker 1>speeding up the approval process, educating consumers and educating providers

0:04:50.360 --> 0:04:54.039
<v Speaker 1>on the effectiveness of these generics and biosimilars, and we

0:04:54.080 --> 0:04:58.360
<v Speaker 1>think those things work. You know, you've also been appounding

0:04:58.400 --> 0:05:03.360
<v Speaker 1>the table about how the Affordable Care Act has affected hospitals,

0:05:03.360 --> 0:05:06.480
<v Speaker 1>and you want to reset the button on pay for

0:05:06.839 --> 0:05:10.440
<v Speaker 1>quality programs, how they're implemented for hospitals, What are they

0:05:10.520 --> 0:05:14.520
<v Speaker 1>and why are they contributing to costs? So, actually, at Premiere,

0:05:14.560 --> 0:05:17.400
<v Speaker 1>we think that there's a lot of bipartisans support, and

0:05:17.400 --> 0:05:21.400
<v Speaker 1>in an election year that's important for these forward looking

0:05:21.520 --> 0:05:25.640
<v Speaker 1>forms of paying for health care. So the idea that

0:05:25.680 --> 0:05:30.880
<v Speaker 1>you as a consumer would have UM your providers have accountability,

0:05:30.920 --> 0:05:34.680
<v Speaker 1>your doctors, your hospitals, your nursing homes, have connected and

0:05:34.720 --> 0:05:41.120
<v Speaker 1>coordinated accountability for the overall clinical efficacy and cost of

0:05:41.200 --> 0:05:45.160
<v Speaker 1>your care, we think has broad bipartisan support. And so

0:05:45.279 --> 0:05:48.800
<v Speaker 1>all these new models that are being rolled out by

0:05:48.920 --> 0:05:53.000
<v Speaker 1>the centers for Medicare and Medicaid, whether it's bundling payments together,

0:05:53.200 --> 0:05:56.920
<v Speaker 1>whether it's something called an accountable care organization, these are

0:05:56.960 --> 0:06:02.200
<v Speaker 1>all designed to try to bring coordination and interoperability of

0:06:02.240 --> 0:06:09.040
<v Speaker 1>technology systems and actually um patient involvement in the overall

0:06:09.120 --> 0:06:13.000
<v Speaker 1>coordination of care delivery. I want if you could talk

0:06:13.040 --> 0:06:16.800
<v Speaker 1>a little bit about prescription drugs, because prescription drugs are

0:06:16.839 --> 0:06:19.920
<v Speaker 1>the most expensive in the United States there twice as

0:06:19.960 --> 0:06:23.719
<v Speaker 1>high as prescription drug prices in the United Kingdom, Australia

0:06:23.839 --> 0:06:27.760
<v Speaker 1>or Canada. Well, I do think and at Premiere we

0:06:27.920 --> 0:06:32.479
<v Speaker 1>see because we do um GPO contracts and we try

0:06:32.520 --> 0:06:37.520
<v Speaker 1>to bring competitive friction to the contracting with pharmaceutical companies.

0:06:37.560 --> 0:06:41.560
<v Speaker 1>But we do see um that the United States funds

0:06:41.600 --> 0:06:44.520
<v Speaker 1>a lot of the innovation and a lot of the

0:06:44.560 --> 0:06:47.880
<v Speaker 1>cost of research and development to bring drugs to market

0:06:48.680 --> 0:06:51.960
<v Speaker 1>UM and we do see that with competition and with

0:06:52.120 --> 0:06:56.720
<v Speaker 1>the use of generics and biosimilars, you can see very

0:06:56.760 --> 0:06:59.240
<v Speaker 1>significant reductions in the price. So if we can get

0:06:59.279 --> 0:07:02.720
<v Speaker 1>generics to the market faster, very often they have an

0:07:02.720 --> 0:07:05.440
<v Speaker 1>eight or nine reduction in the price of the drug.

0:07:05.520 --> 0:07:09.120
<v Speaker 1>If we can get these biosimilars to market like they've

0:07:09.160 --> 0:07:12.400
<v Speaker 1>gotten them to market in Europe, uh, you'll see a

0:07:12.480 --> 0:07:16.640
<v Speaker 1>thirty reduction in the price of those drugs. So again

0:07:16.760 --> 0:07:21.080
<v Speaker 1>we think it's having clinical data on how these equivalent

0:07:21.120 --> 0:07:24.040
<v Speaker 1>drugs work. Speeding up the f d A. R f

0:07:24.160 --> 0:07:28.400
<v Speaker 1>d A is a very long process and cycle time,

0:07:28.480 --> 0:07:30.120
<v Speaker 1>so so we think there are a lot of things

0:07:30.120 --> 0:07:33.320
<v Speaker 1>that can be done to improve this Sits DeVore, President

0:07:33.440 --> 0:07:37.200
<v Speaker 1>CEO of Premiere on the front lines of dealing with

0:07:37.520 --> 0:07:41.280
<v Speaker 1>the health care system, and Kathie Hayes along with PM Fox,

0:07:41.560 --> 0:07:47.320
<v Speaker 1>This is Bloomberg. Bloomberg taking Stock is brought to by

0:07:47.320 --> 0:07:50.200
<v Speaker 1>Time winner Cable Business Class. If your business relies on

0:07:50.240 --> 0:07:52.960
<v Speaker 1>the phone company, you may be getting less than you deserve.

0:07:53.120 --> 0:07:55.840
<v Speaker 1>Make the switch to more speed, more value, more savings.

0:07:56.160 --> 0:07:59.240
<v Speaker 1>Visit Business dot t WC dot com, slash more